Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2020 Dec;10(2):e97-e185.
doi: 10.1016/j.kisu.2020.09.001. Epub 2020 Dec 1.

China Kidney Disease Network (CK-NET) 2016 Annual Data Report

Luxia Zhang  1   2   3 , Ming-Hui Zhao  1   4   5 , Li Zuo  6 , Yue Wang  7 , Feng Yu  1   4   8 , Hong Zhang  1   4 , Haibo Wang  2 ; CK-NET Work Group
Affiliations

China Kidney Disease Network (CK-NET) 2016 Annual Data Report

Luxia Zhang et al. Kidney Int Suppl (2011). 2020 Dec.
No abstract available

PubMed Disclaimer

Figures

Figure 1
Figure 1
Prevalence of CKD among different types of underlying disease. CKD, chronic kidney disease; CVD, cardiovascular disease; DM, diabetes mellitus; HT, hypertension.
Figure 2
Figure 2
Patients with CKD, stratified by sex and age. CKD, chronic kidney disease.
Figure 3
Figure 3
Patients with CKD, stratified by urban versus rural area (percent values). CKD, chronic kidney disease.
Figure 4
Figure 4
Age distribution of patients with CKD, stratified by sex. CKD, chronic kidney disease.
Figure 5
Figure 5
Sex distribution of patients with CKD, stratified by age. Digits in columns represent percent values. CKD, chronic kidney disease.
Figure 6
Figure 6
Cause distribution of patients with CKD. Digits above columns represent percent values. CKD, chronic kidney disease; CTIN, chronic tubulointerstitial nephropathy; DKD, diabetic kidney disease; GN, glomerulonephritis; HTN, hypertensive nephropathy; ON, obstructive nephropathy; Others, CKD due to other reasons.
Figure 7
Figure 7
Cause of patients with CKD, stratified by urban versus rural area. Digits above columns represent percent values. CKD, chronic kidney disease; CTIN, chronic tubulointerstitial nephropathy; DKD, diabetic kidney disease; GN, glomerulonephritis; HTN, hypertensive nephropathy; ON, obstructive nephropathy; Others, CKD due to other reasons.
Figure 8
Figure 8
Cause of patients with CKD, stratified by geographic region. C, Central China; CKD, chronic kidney disease; CTIN, chronic tubulointerstitial nephropathy; DKD, diabetic kidney disease; E, East China; GN, glomerulonephritis; HTN, hypertensive nephropathy; N, North China; NE, Northeast China; NW, Northwest China; ON, obstructive nephropathy; Others, CKD due to other reasons; S, South China; SW, Southwest China.
Figure 9
Figure 9
Staging of CKD, stratified by hospital nephrology unit. CKD, chronic kidney disease.
Figure 10
Figure 10
The travel pattern of patients with CKD. Reference line represents the overall percentage of flow of CKD (5.98%). C, Central China; CKD, chronic kidney disease; E, East China; N, North China; NE, Northeast China; NW, Northwest China; S, South China; SW, Southwest China.
Figure 11
Figure 11
Prevalence of CVD, stratified by patient group. CHD, coronary heart disease; CKD, chronic kidney disease; CVD, cardiovascular disease; DM, diabetes mellitus.
Figure 12
Figure 12
Prevalence of CHD, stratified by sex. CHD, coronary heart disease; CKD, chronic kidney disease; DM, diabetes mellitus.
Figure 13
Figure 13
Prevalence of CHD, stratified by age. Point size refers to the percentage of CHD. CHD, coronary heart disease; CKD, chronic kidney disease; DM, diabetes mellitus.
Figure 14
Figure 14
Prevalence of stroke, stratified by sex. CKD, chronic kidney disease; DM, diabetes mellitus.
Figure 15
Figure 15
Prevalence of stroke, stratified by age. Point size refers to the percentage of stroke. CKD, chronic kidney disease; DM, diabetes mellitus.
Figure 16
Figure 16
Prevalence of heart failure, stratified by sex. CKD, chronic kidney disease; DM, diabetes mellitus.
Figure 17
Figure 17
Prevalence of heart failure, stratified by age. Point size refers to the percentage of heart failure. CKD, chronic kidney disease; DM, diabetes mellitus.
Figure 18
Figure 18
Prevalence of atrial fibrillation, stratified by sex. CKD, chronic kidney disease; DM, diabetes mellitus.
Figure 19
Figure 19
Prevalence of atrial fibrillation, stratified by age. Point size refers to the percentage of atrial fibrillation. CKD, chronic kidney disease; DM, diabetes mellitus.
Figure 20
Figure 20
Prevalence of CVD among patients with CKD. CHD, coronary heart disease; CKD, chronic kidney disease; CTIN, chronic tubulointerstitial nephropathy; CVD, cardiovascular disease; DKD, diabetic kidney disease; GN, glomerulonephritis; HTN, hypertensive nephropathy; ON, obstructive nephropathy; Others, CKD due to other reasons.
Figure 21
Figure 21
Prevalence of CHD among patients with CKD, stratified by nephropathy type and sex. CHD, coronary heart disease; CKD, chronic kidney disease; CTIN, chronic tubulointerstitial nephropathy; DKD, diabetic kidney disease; GN, glomerulonephritis; HTN, hypertensive nephropathy; ON, obstructive nephropathy; Others, CKD due to other reasons.
Figure 22
Figure 22
Prevalence of CHD among patients with CKD, stratified by nephropathy type and age. Point size refers to the percentage of CHD. CHD, coronary heart disease; CKD, chronic kidney disease; CTIN, chronic tubulointerstitial nephropathy; DKD, diabetic kidney disease; GN, glomerulonephritis; HTN, hypertensive nephropathy; ON, obstructive nephropathy; Others, CKD due to other reasons.
Figure 23
Figure 23
Prevalence of stroke among patients with CKD, stratified by nephropathy type and sex. CKD, chronic kidney disease; CTIN, chronic tubulointerstitial nephropathy; DKD, diabetic kidney disease; GN, glomerulonephritis; HTN, hypertensive nephropathy; ON, obstructive nephropathy; Others, CKD due to other reasons.
Figure 24
Figure 24
Prevalence of stroke among patients with CKD, stratified by nephropathy type and age. Point size refers to the percentage of stroke. CKD, chronic kidney disease; CTIN, chronic tubulointerstitial nephropathy; DKD, diabetic kidney disease; GN, glomerulonephritis; HTN, hypertensive nephropathy; ON, obstructive nephropathy; Others, CKD due to other reasons.
Figure 25
Figure 25
Prevalence of heart failure among patients with CKD, stratified by nephropathy type and sex. CKD, chronic kidney disease; CTIN, chronic tubulointerstitial nephropathy; DKD, diabetic kidney disease; GN, glomerulonephritis; HTN, hypertensive nephropathy; ON, obstructive nephropathy; Others, CKD due to other reasons.
Figure 26
Figure 26
Prevalence of heart failure among patients with CKD, stratified by nephropathy type and age. Point size refers to the percentage of heart failure. CKD, chronic kidney disease; CTIN, chronic tubulointerstitial nephropathy; DKD, diabetic kidney disease; GN, glomerulonephritis; HTN, hypertensive nephropathy; ON, obstructive nephropathy; Others, CKD due to other reasons.
Figure 27
Figure 27
Prevalence of atrial fibrillation among patients with CKD, stratified by nephropathy type and sex. CKD, chronic kidney disease; CTIN, chronic tubulointerstitial nephropathy; DKD, diabetic kidney disease; GN, glomerulonephritis; HTN, hypertensive nephropathy; ON, obstructive nephropathy; Others, CKD due to other reasons.
Figure 28
Figure 28
Prevalence of atrial fibrillation among patients with CKD, stratified by nephropathy type and age. Point size refers to the percentage of atrial fibrillation. CKD, chronic kidney disease; CTIN, chronic tubulointerstitial nephropathy; DKD, diabetic kidney disease; GN, glomerulonephritis; HTN, hypertensive nephropathy; ON, obstructive nephropathy; Others, CKD due to other reasons.
Figure 29
Figure 29
Cardiovascular procedures stratified by patient group. CABG, coronary artery bypass grafting; CAG, coronarography; CKD, chronic kidney disease; DM, diabetes mellitus; PCI, percutaneous coronary intervention.
Figure 30
Figure 30
Cardiovascular procedure: CAG, stratified by sex. CAG, coronarography; CKD, chronic kidney disease; DM, diabetes mellitus.
Figure 31
Figure 31
Cardiovascular procedure: CAG, stratified by age. CAG, coronarography; CKD, chronic kidney disease; DM, diabetes mellitus. Point size refers to the percentage of CAG.
Figure 32
Figure 32
Cardiovascular procedure: PCI, stratified by sex. CKD, chronic kidney disease; DM, diabetes mellitus; PCI, percutaneous coronary intervention.
Figure 33
Figure 33
Cardiovascular procedure: PCI, stratified by age. CKD, chronic kidney disease; DM, diabetes mellitus; PCI, percutaneous coronary intervention. Point size refers to the percentage of PCI.
Figure 34
Figure 34
Cardiovascular procedure: CABG, stratified by sex. CABG, coronary artery bypass grafting; CKD, chronic kidney disease; DM, diabetes mellitus.
Figure 35
Figure 35
Cardiovascular procedure: CABG, stratified by age. CABG, coronary artery bypass grafting; CKD, chronic kidney disease; DM, diabetes mellitus. Point size refers to the percentage of CABG.
Figure 36
Figure 36
Cardiovascular procedure: pacemaker, stratified by sex. CKD, chronic kidney disease; DM, diabetes mellitus.
Figure 37
Figure 37
Cardiovascular procedure: pacemaker, stratified by age. Point size refers to the percentage of pacemaker. CKD, chronic kidney disease; DM, diabetes mellitus.
Figure 38
Figure 38
Cardiovascular procedures among patients with CKD. CABG, coronary artery bypass grafting; CAG, coronarography; CKD, chronic kidney disease; CTIN, chronic tubulointerstitial nephropathy; DKD, diabetic kidney disease; GN, glomerulonephritis; HTN, hypertensive nephropathy; ON, obstructive nephropathy; Others, CKD due to other reasons; PCI, percutaneous coronary intervention.
Figure 39
Figure 39
Costs stratified by types of health insurance. The box plot shows the distribution of hospitalization costs for different types of health insurance. Limited to 1.5 * third quartile. Red points refer to cost per person per year. CKD, chronic kidney disease; DM, diabetes mellitus; NRCMS, new rural co-operative medical care; UBMI, urban basic medical insurance.
Figure 40
Figure 40
Costs stratified by sex. The box plot shows the distribution of hospitalization costs by sex. Limited to 1.5 * third quartile. Red points refer to cost per person per year. CKD, chronic kidney disease; DM, diabetes mellitus.
Figure 41
Figure 41
Costs stratified by age group (mean). CKD, chronic kidney disease; DM, diabetes mellitus.
Figure 42
Figure 42
Length of hospital stay stratified by types of health insurance. Limited to 1.5 * third quartile. Red points refer to LOS per person per year. CKD, chronic kidney disease; DM, diabetes mellitus; LOS, length of hospital stay; NRCMS, new rural co-operative medical care; UBMI, urban basic medical insurance.
Figure 43
Figure 43
Length of hospital stay stratified by sex. Limited to 1.5 * third quartile. Red points refer to LOS per person per year. CKD, chronic kidney disease; DM, diabetes mellitus; LOS, length of hospital stay.
Figure 44
Figure 44
Length of hospital stay stratified by age group (mean). CKD, chronic kidney disease; DM, diabetes mellitus; LOS, length of hospital stay.
Figure 45
Figure 45
In-hospital mortality stratified by different types of insurance. CKD, chronic kidney disease; DM, diabetes mellitus; NRCMS, new rural co-operative medical care; UBMI, urban basic medical insurance.
Figure 46
Figure 46
In-hospital mortality stratified by sex. CKD, chronic kidney disease; DM, diabetes mellitus.
Figure 47
Figure 47
In-hospital mortality stratified by age group. Point size refers to mortality rate. CKD, chronic kidney disease; DM, diabetes mellitus.
Figure 48
Figure 48
Percentage of AKI with and without ICU stay, stratified by geographic region. AKI, acute kidney injury; C, Central of China; E, East of China; ICU, intensive care unit; N, North of China; NE, Northeast of China; NW, Northwest of China; S, South of China; SW, Southwest of China.
Figure 49
Figure 49
Percentage of AKI among patients with CKD. AKI, acute kidney injury; CKD, chronic kidney disease; CTIN, chronic tubulointerstitial nephropathy; DKD, diabetic kidney disease; GN, glomerulonephritis; HTN, hypertensive nephropathy; ON, obstructive nephropathy; Others, CKD due to other reasons.
Figure 50
Figure 50
Age distribution of AKI patients, stratified by sex. AKI, acute kidney injury.
Figure 51
Figure 51
Sex distribution of AKI patients, stratified by age. AKI, acute kidney injury.
Figure 52
Figure 52
Percentage of CKD among patients with AKI, stratified by sex and age. AKI, acute kidney injury; CKD, chronic kidney disease.
Figure 53
Figure 53
Percentage of diabetes mellitus among patients with AKI, stratified by sex and age. AKI, acute kidney injury.
Figure 54
Figure 54
Distribution of HD and PD patients among different hospital levels. HD, hemodialysis; PD, peritoneal dialysis.
Figure 55
Figure 55
Incidence of dialysis patients, stratified by age and sex. PMP, per million population.
Figure 56
Figure 56
Percentage of dialysis patients who underwent 1 or more measurements of (a) hemoglobin and (b) serum ferritin in 2016. HD, hemodialysis; PD, peritoneal dialysis.
Figure 57
Figure 57
Percentage of dialysis patients who underwent 1 or more measurements of (a) serum calcium, (b) serum phosphorus, and (c) serum parathyroid hormone in 2016. HD, hemodialysis; PD, peritoneal dialysis; PTH, parathyroid hormone.
Figure 58
Figure 58
Percentage of dialysis patients receiving anemia-related treatment. EPO, erythropoietin; HD, hemodialysis; PD, peritoneal dialysis.
Figure 59
Figure 59
Percentage of dialysis patients receiving MBD-related treatment. HD, hemodialysis; MBD, mineral and bone disorder; PD, peritoneal dialysis.
Figure 60
Figure 60
Percentage of dialysis patients who underwent blood albumin testing. HD, hemodialysis; PD, peritoneal dialysis.
Figure 61
Figure 61
Diabetes-related examinations among dialysis patients with diabetes. HD, hemodialysis; PD, peritoneal dialysis.
Figure 62
Figure 62
Percentages of different types of CVD among dialysis patients, by modality. AF, atrial fibrillation; AMI, acute myocardial infarction; CHD, coronary heart disease; CVA/TIA, cerebrovascular accident/transient ischemic attack; CVD, cardiovascular disease; HD, hemodialysis; HF, heart failure; PAD, peripheral arterial disease; PD, peritoneal dialysis.
Figure 63
Figure 63
Percentages of dialysis patients receiving cardiovascular procedures, by modality. HD, hemodialysis; PCI, percutaneous coronary intervention; PD, peritoneal dialysis.
Figure 64
Figure 64
Geographical location of Shandong, Zhejiang, and Xinjiang provinces in China. Shandong and Zhejiang are in the east of China, and Xinjiang is in the northwest of China.
Figure 65
Figure 65
Hepatitis B/C virus infection in (a) HD and (b) PD patients in Shandong, Zhejiang, and Xinjiang in China (%). Data on PD in Shandong Province were not provided. HD, hemodialysis; PD, peritoneal dialysis.
See this image and copyright information in PMC

References

    1. GBD Chronic Kidney Disease Collaboration Global, regional, and national burden of chronic kidney disease, 1990–2017: a systematic analysis for the Global Burden of Disease Study 2017. Lancet (London, England) 2020;395:709–733. - PMC - PubMed
    1. Foreman K.J., Marquez N., Dolgert A. Forecasting life expectancy, years of life lost, and all-cause and cause-specific mortality for 250 causes of death: reference and alternative scenarios for 2016–40 for 195 countries and territories. Lancet (London, England) 2018;392:2052–2090. - PMC - PubMed
    1. Zhang L., Wang F., Wang L. Prevalence of chronic kidney disease in China: a cross-sectional survey. Lancet (London, England) 2012;379:815–822. - PubMed
    1. Liu Z.H. Nephrology in china. Nat Rev Nephrol. 2013;9:523–528. - PubMed
    1. Yang C., Kong G., Wang L. Big data in nephrology: Are we ready for the change? Nephrology (Carlton) 2019;24:1097–1102. - PubMed